Farther Finance Advisors, LLC Mirati Therapeutics, Inc. Transaction History

Farther Finance Advisors, LLC

  • $2.67 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
SELL
$0.0 - $59.28 $0 - $889
-15 Closed
0 $0
Q4 2023

Feb 14, 2024
BUY
$41.99 - $62.38 $1,805 - $2,682
43 Added 286.67%
58 $3.41 Million
Q2 2023

May 13, 2024
SELL
$36.13 - $49.49 $1,553 - $2,128
-43 Reduced 74.14%
15 $542,000
Q2 2023

Sep 12, 2023
BUY
$36.13 - $49.49 $541 - $742
15 New
15 $542,000

Others Institutions Holding MRTX

# of Institutions
16
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email